| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |